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Abstract
Background Abdominoperineal resection (APR) carries a high risk of perineal wound morbidity. Perineal wound closure 
using autologous tissue flaps has been shown to be advantageous, but there is no consensus as to the optimal method. The 
aim of this study was to evaluate the feasibility of a novel gluteal turnover flap (GT-flap) without donor site scar for perineal 
closure after APR.
Methods Consecutive patients who underwent APR for primary or recurrent rectal cancer were included in a prospective 
non-randomised pilot study in two academic centres. Perineal reconstruction consisted of a unilateral subcutaneous GT-flap, 
followed by midline closure. Feasibility was defined as uncomplicated perineal wound healing at 30 days in at least five 
patients, and a maximum of two flap failures.
Results Out of 17 potentially eligible patients, 10 patients underwent APR with GT-flap-assisted perineal wound closure. 
Seven patients had pre-operative radiotherapy. Median-added theatre time was 38 min (range 35–44 min). Two patients 
developed a superficial perineal wound dehiscence, most likely because of the excessive width of the skin island. Two other 
patients developed purulent discharge and excessive serosanguinous discharge, respectively, resulting in four complicated 
wounds at 30 days. No flap failure occurred, and no radiological or surgical reinterventions were performed. Median length 
of hospital stay was 10 days (IQR 8–12 days).
Conclusions The GT-flap for routine perineal wound closure after APR seems feasible with limited additional theatre time, 
but success seems to depend on correct planning of the width of the flap. The potential for reducing perineal morbidity should 
be evaluated in a randomised controlled trial.
Keywords Rectal neoplasms · Abdominoperineal resection · Surgical flaps · Tissue transfer · Gluteal turnover flap · 
Perineal wound healing
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Introduction
To date, abdominoperineal resection (APR) for low rectal 
cancer still carries a significant risk of perineal wound prob-
lems [1]. A recent randomised controlled trial on perineal 
wound closure after APR reported an incidence of compli-
cated perineal wound healing of 34–37% at 30 days post-
operatively [2], but perineal complications have even been 
reported to occur in up to 66% of patients after APR and 
primary closure [3]. In addition, patients may experience 
persisting perineal pain, or develop a chronic perineal sinus 
or perineal hernia [4–6].
The high risk of perineal morbidity after APR is related 
to the creation of a large pelvic dead space with bacterial 
contamination, making the surgical-site susceptible for 
infection. Furthermore, the use of pre-operative radiother-
apy significantly impairs the healing capacity of this dead 
space—secondary to the decreased angiogenesis. To prevent 
these wound problems, immediate soft-tissue reconstruction 
has been advocated [7]. The rationale is that by obliterating 
the surgical dead space with well-vascularised tissues, the 
risk of wound breakdown and infection is reduced. Another 
reason is related to the concept that autologous tissue may 
add strength to the (partially) excised pelvic floor muscles, 
which may potentially reduce the risk of perineal hernia 
formation. There is, however, no consensus on the optimal 
method for perineal wound closure after APR.
Several techniques are used to improve perineal wound 
healing, including reconstruction using a V–Y fasciocutane-
ous flap, a vertical rectus abdominis myocutaneous (VRAM) 
flap, a gluteal, or a gracilis flap [8–11]. However, there are 
potential disadvantages to these techniques. These include 
the need for a plastic surgeon, a substantially increased thea-
tre time and the potential for donor site and recipient site 
complications while often sacrificing the benefits of lapa-
roscopy [12–17]. Moreover, as a large percentage of patients 
will not develop healing difficulties, immediate reconstruc-
tion with large muscle flaps might be an unnecessary risk 
and expense. An optimal harm–benefit ratio of reconstruc-
tive techniques is especially important in relatively low-risk 
patients undergoing non-extensive resections without pre-
operative radiotherapy. There is an urgent need for a simple 
and minimally invasive technique for routine perineal wound 
closure after APR. We propose a novel unilateral subcutane-
ous gluteal turnover flap (GT-flap) without additional scar-
ring or donor site morbidity.
The aim of this pilot study was to determine the feasibil-
ity of this procedure in patients who underwent APR for 
primary or recurrent rectal cancer.
Materials and methods
Design and patients
A prospective longitudinal multicentre interventional 
cohort study was performed in ten consecutive patients at 
two academic medical centres. All patients scheduled for 
extralevator APR were pre-operatively informed on the 
study in the outpatient clinics. Written informed consent 
was obtained for all participants. Inclusion criteria were 
adult patients (age ≥ 18 years) and planned for APR for 
primary or recurrent rectal cancer. Exclusion criteria were 
need for total pelvic exenteration, sacral resection above 
S4/S5, severe concomitant diseases affecting wound heal-
ing (i.e., renal failure requiring dialysis, liver cirrhosis, 
and peripheral vascular disease with Fontaine grade 3 or 
higher), or enrolment in other trials expected to influence 
perineal wound healing.
On day 7 and day 30 after surgery, the perineal wound 
was evaluated by residents or surgeons using the South-
ampton wound score (supplementary Table 1). Postop-
erative pain was assessed using the visual analogue scale 
(VAS) which ranged from 0 (no pain) to 10 (worst pain). 
In addition, photographs were taken, and all appointed 
wound scores were centrally reviewed by the trial coordi-
nators (RDB and PJT). Patient demographics, neo-adju-
vant treatment, tumour characteristics, and surgical details 
were intra-operatively collected. Postoperatively, type and 
extent of any wound event or any other adverse event, and 
all medical, radiological and surgical interventions were 
recorded to the last day of follow-up. The study protocol 
was approved by the Institutional Review Board of the 
Amsterdam UMC, University of Amsterdam, and the Eras-
mus MC (NL58380.018.16).
Surgical procedure
All patients received antibiotic prophylaxis with Cefazolin 
and Metronidazole, with a repeat dose in case of prolonged 
surgery (> 4 h from time of first pre-operative dose). This 
was not extended postoperatively. APR started with skin 
incision close to the anus with subsequent dissection along 
the external sphincter, to preserve as much perineal skin 
and subcutaneous fat as possible without compromising 
oncologically safety.
Perineal reconstruction is then performed using a uni-
lateral, semilunar, de-epithelialised, subcutaneous GT-flap 
(Fig. 1). Creation of the GT-flap starts with drawing of a 
semi-circular incision adjacent to the surgical defect of 
approximately two-and-a-half centimetre in width. Suc-
cess of the flap is contingent upon obtaining tension-free 
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closure at the midline. For this reason, the flap can only 
be a few centimetres in width. Pre-operative mapping of 
the perforators is not deemed necessary due to the broad 
base of the turnover flap and its robust blood supply. Fur-
thermore, due to the design of the flap, there is no need 
to elevate the flap on a single perforator. The flap is de-
epithelialised followed by incision through the skin and 
slightly lateral dissection towards the gluteus muscle. It is 
important to perform the de-epithelialisation before dis-
secting the flap, as this makes it easier. The flap is then 
hinged into the defect, and the dermis is anchored to the 
contra-lateral remnants of the levator muscles. Next, a 
vacuum drain is positioned on top of the flap and the sub-
cutaneous fat and perineal skin are closed in a layered 
fashion in the midline over the flap.
Patients were allowed to mobilise on the first postopera-
tive day, but were instructed not to sit directly on the perineal 
wound for the first few days. The drain was removed after at 
least 3 days according to the surgeons’ judgement.
Feasibility criteria and secondary outcome 
measures
The procedure was deemed feasible if (1) no more than five 
patients had a complicated wound healing at 30 days post-
operatively and (2) including no more than two flap failures. 
Complicated wound healing was defined as a Southamp-
ton wound score equal or greater than II (supplementary 
Table 1). We hypothesised that, since the flap is covered 
and not visually accessible for evaluation of flap perfusion, 
Fig. 1  Reconstruction of an 
abdominoperineal defect 
using a gluteal turnover flap. 
a marking of the flap, b de-
epithelialisation of the dermis, c 
flap after having transected onto 
the gluteal fascia, d rotation of 
the flap, e fixation of flap to the 
contra-lateral remnants of pelvic 
floor muscles, f midline scar 
following layered closure of the 
ischiorectal and perineal tissues 
over the flap
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flap failure would eventually result in wound breakdown. 
Therefore, flap failure was defined as a Southampton wound 
score of V.
Secondary endpoints were median length of the proce-
dure, length of hospital stay, number of specific complica-
tions, and number of reinterventions and readmissions.
Statistical analysis
Categorical data were expressed as absolute numbers with 
corresponding proportions and continuous data according to 
distribution as means with standard deviation (SD) or medi-
ans with interquartile range (IQR). The treatment effect was 
determined based on a per-protocol analysis. All analyses 
were performed with IBM SPSS statistics, version 24.0.0 
(IBM Corp., Armonk, NY, USA).
Results
Among 17 eligible patients, 11 were willing to participate 
and signed informed consent. Patient characteristics are 
demonstrated in Table 1. The mean age was 64 years (range 
44–79 years) and 7 were male. Indications for APR were 
primary rectal cancer (n = 8), recurrent rectal cancer (n = 2), 
and one patient that had a clinical diagnosis of rectal cancer, 
but appeared to have recurrent prostate cancer on postopera-
tive pathological examination. Pre-operative radiotherapy 
was given to eight patients.
Surgical details are shown in Table 2. In one case, it was 
not thought to be possible to obtain tension-free midline 
closure using a GT-flap due to the large size of the perineal 
skin defect after resection. A GT-flap with midline perineal 
closure could be performed in the remaining ten patients. 
Median total theatre time was 305 min (IQR 249–370 min), 
and median time taken for flap harvesting and insertion into 
the neo-pelvic floor was 38 min (IQR 35–44 min).
Surgical outcome
Median length of follow-up was 33 days (IQR 27–35 days). 
Postoperative outcomes are displayed in Table 3. Median 
length of hospital stay was 10 days (IQR 8–12 days). In 
total, 4 patients had a complicated perineal wound healing 
at 30 days (Southampton wound score ≥ II). Two patients 
developed a superficial dehiscence of a few centimetres in 
depth, one with concomitant pus discharge. The underlying 
GT-flaps were unaffected (Fig. 2). Retrospective evaluation 
of these two patients revealed that the design of the flap was 
too wide, resulting in tension on the perineal wound after 
midline closure. Both patients needed no further treatment 
besides irrigation with saline. One patient developed per-
ineal infection with a small pus pocket necessitating manual Ta
bl
e 
1 
 Pa
tie
nt
 ch
ar
ac
ter
ist
ics
BM
I b
od
y m
as
s i
nd
ex
, A
SA
 A
m
er
ica
n S
oc
iet
y o
f A
na
es
th
es
io
lo
gi
sts
 cl
as
sifi
ca
tio
n, 
TM
E 
to
tal
 m
es
or
ec
tal
 ex
cis
io
n, 
AR
J a
no
re
cta
l j
un
cti
on
, N
A 
no
t a
pp
lic
ab
le,
 M
RF
 m
es
or
ec
tal
 fa
sc
ia
a  P
ati
en
t w
as
 ex
clu
de
d i
nt
ra
-o
pe
ra
tiv
ely
Pa
tie
nt
Ag
e (
ye
ar
s)
Se
x
BM
I (
kg
/m
2 )
AS
A
Sm
ok
in
g
Di
ab
ete
s
Pr
io
r p
elv
ic 
su
rg
er
y
In
di
ca
tio
n
Di
sta
nc
e A
RJ
 (c
m
)
Th
re
at-
en
ed
 
M
RF
Ne
o-
ad
ju
va
nt
 th
er
ap
y
1
59
F
28
.4
II
Ne
ve
r
Ye
s
Hy
ste
re
cto
m
y
Pr
im
ar
y r
ec
tal
 ca
nc
er
1
Ye
s
Ra
di
o-
ch
em
ot
he
ra
py
2
67
F
23
.1
II
Ne
ve
r
No
No
ne
Pr
im
ar
y r
ec
tal
 ca
nc
er
3
Ye
s
Ra
di
o-
ch
em
ot
he
ra
py
3
79
M
28
.7
II
Ne
ve
r
No
No
ne
Re
cu
rre
nt
 pr
os
tat
e c
an
ce
r
NA
NA
No
ne
4
48
M
31
.8
II
Ne
ve
r
No
Tr
an
sa
na
l  T
M
EN
A
Re
cu
rre
nt
 re
cta
l c
an
ce
r
0
NA
No
ne
5
68
M
27
.8
III
Ne
ve
r
No
No
ne
Pr
im
ar
y r
ec
tal
 ca
nc
er
4
Ye
s
Ra
di
o-
ch
em
ot
he
ra
py
6a
71
M
27
.93
III
St
op
pe
d >
 10
 ye
ar
s
No
Pr
os
tat
ec
to
m
y
Pr
im
ar
y r
ec
tal
 ca
nc
er
0
Ye
s
Ra
di
o-
ch
em
ot
he
ra
py
7
68
F
33
.9
II
Ne
ve
r
No
No
ne
Pr
im
ar
y r
ec
tal
 ca
nc
er
0
Ye
s
Ra
di
o-
ch
em
ot
he
ra
py
8
66
M
26
.5
I
St
op
pe
d <
 10
 ye
ar
s
No
No
ne
Pr
im
ar
y r
ec
tal
 ca
nc
er
1
No
No
ne
9
44
M
32
.7
II
St
op
pe
d <
 10
 ye
ar
s
No
No
ne
Pr
im
ar
y r
ec
tal
 ca
nc
er
M
iss
in
g
Ye
s
Ra
di
o-
ch
em
ot
he
ra
py
10
73
F
30
.0
III
St
op
pe
d >
 10
 ye
ar
s
Ye
s
Hy
ste
re
cto
m
y
Pr
im
ar
y r
ec
tal
 ca
nc
er
M
iss
in
g
Ye
s
Ra
di
o-
ch
em
ot
he
ra
py
11
68
M
27
.2
I
St
op
pe
d <
 10
 ye
ar
s
No
La
pa
ro
sc
op
ic 
TM
E
Re
cu
rre
nt
 re
cta
l c
an
ce
r
9
NA
Ra
di
o-
ch
em
ot
he
ra
py
Techniques in Coloproctology 
1 3
Ta
bl
e 
2 
 Su
rg
ica
l d
eta
ils
 an
d i
nt
ra
-o
pe
ra
tiv
e o
ut
co
m
e
AP
R 
ab
do
m
in
op
er
in
ea
l r
es
ec
tio
n, 
NA
 no
t a
pp
lic
ab
le,
 T
AM
IS
 tr
an
sp
er
in
ea
l m
in
im
all
y i
nv
as
ive
 su
rg
er
y (
us
in
g G
elP
OI
NT
 pa
th
 an
d A
irs
ea
l),
 In
tra
op
 R
XT
 in
tra
-o
pe
ra
tiv
e r
ad
io
th
er
ap
y
a  T
im
e i
n m
in
ut
es
Pa
tie
nt
Ty
pe
 of
 
AP
R
Po
sit
io
n
Ab
do
m
in
al 
ap
pr
oa
ch
Pe
rin
ea
l 
ap
pr
oa
ch
Ad
jac
en
t 
or
ga
n r
es
ec
-
tio
n
In
tra
op
 
RT
X
Om
en
to
-
pl
as
ty
Ab
do
m
-
in
al 
dr
ain
Ty
pe
 of
 
su
rg
eo
n
Bu
tto
ck
Pe
rin
ea
l 
dr
ain
Sk
in
 cl
o-
su
re
Re
co
n-
str
uc
tio
n 
 tim
ea
To
tal
 th
ea
tre
 
 tim
ea
1
Ex
tra
lev
ato
r
Li
th
ot
om
y
Op
en
Op
en
No
ne
No
Ye
s
Ye
s
Pl
as
tic
Le
ft
Ye
s
Tr
an
sc
ut
a-
ne
ou
s
42
20
7
2
Ex
tra
lev
ato
r
Li
th
ot
om
y
Op
en
Op
en
No
ne
No
Ye
s
Ye
s
Pl
as
tic
Le
ft
Ye
s
Tr
an
sc
ut
a-
ne
ou
s
55
51
0
3
Ex
tra
lev
ato
r
Li
th
ot
om
y
Op
en
Op
en
No
ne
No
Ye
s
Ye
s
Ge
ne
ra
l
Le
ft
Ye
s
Tr
an
sc
ut
a-
ne
ou
s
45
30
2
4
Ex
tra
lev
ato
r
Li
th
ot
om
y
La
pa
ro
-
sc
op
ic
Op
en
No
ne
No
No
Ye
s
Pl
as
tic
Le
ft
Ye
s
In
tra
cu
ta-
ne
ou
s
35
15
1
5
Ex
tra
lev
ato
r
Li
th
ot
om
y
Op
en
Op
en
No
ne
No
Ye
s
Ye
s
Pl
as
tic
Ri
gh
t
Ye
s
Tr
an
sc
ut
a-
ne
ou
s
38
30
5
6
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
7
Ex
tra
lev
ato
r
Li
th
ot
om
y
Op
en
Op
en
No
ne
No
Ye
s
Ye
s
Ge
ne
ra
l
Le
ft
Ye
s
Tr
an
sc
ut
a-
ne
ou
s
36
32
7
8
Ex
tra
lev
ato
r
Pr
on
e
La
pa
ro
-
sc
op
ic
Op
en
No
ne
No
No
Ye
s
Pl
as
tic
Ri
gh
t
Ye
s
In
tra
cu
ta-
ne
ou
s
M
iss
in
g
M
iss
in
g
9
Ex
tra
lev
ato
r
Li
th
ot
om
y
La
pa
ro
-
sc
op
ic
TA
M
IS
No
ne
No
No
Ye
s
Pl
as
tic
Le
ft
Ye
s
In
tra
cu
ta-
ne
ou
s
35
31
0
10
Ex
tra
lev
ato
r
Li
th
ot
om
y
La
pa
ro
-
sc
op
ic
TA
M
IS
Po
ste
rio
r 
va
gi
ne
c-
to
m
y
No
No
No
Ge
ne
ra
l
Le
ft
Ye
s
In
tra
cu
ta-
ne
ou
s
31
29
1
11
Ex
tra
lev
ato
r
Li
th
ot
om
y
Op
en
Op
en
Le
ft 
pe
lv
ic 
sid
ew
all
Ye
s
Ye
s
Ye
s
Pl
as
tic
Ri
gh
t
No
Tr
an
sc
ut
a-
ne
ou
s
40
41
2
 Techniques in Coloproctology
1 3
Ta
bl
e 
3 
 Sh
or
t-t
er
m
 ou
tco
m
e a
fte
r a
bd
om
in
op
er
in
ea
l r
es
ec
tio
n a
nd
 gl
ut
ea
l t
ur
no
ve
r fl
ap
NA
 no
t a
pp
lic
ab
le,
 V
AS
 vi
su
al 
an
alo
gu
e p
ain
 sc
ale
 (m
ea
su
re
d a
t r
es
t),
 A
B 
an
tib
io
tic
 th
er
ap
y, 
U
TI
 ur
in
ar
y t
ra
ct 
in
fec
tio
n, 
TP
N
 to
tal
 pa
re
nt
er
al 
nu
tri
tio
n, 
I&
D
 in
cis
io
n a
nd
 dr
ain
ag
e
a  R
ec
ur
re
nt
 pr
os
tat
e c
an
ce
r
b  A
cc
or
di
ng
 to
 th
e S
ou
th
am
pt
on
 W
ou
nd
 S
co
rin
g S
ys
tem
Pa
tie
nt
Hi
sto
pa
th
ol
og
y
Ho
sp
i-
tal
 st
ay
 
(d
ay
s)
7-
da
y 
wo
un
d 
 sc
or
eb
30
-d
ay
 
wo
un
d 
 sc
or
eb
VA
S 
7 d
ay
s
VA
S 
30
 da
ys
Pe
rin
ea
l c
om
pl
ica
-
tio
ns
Pe
rin
ea
l r
ein
ter
ve
n-
tio
ns
Ot
he
r c
om
pl
ica
tio
ns
Ot
he
r i
nt
er
ve
nt
io
ns
Fo
llo
w-
up
 
(d
ay
s)
1
pT
0N
0M
x
8
0
0
0
0
No
ne
No
ne
UT
I, 
ur
in
ar
y r
ete
nt
io
n
AB
 fo
r U
TI
35
2
pT
0N
0M
x
10
I
IV
2
1
In
fec
tio
n
M
an
ua
l d
ra
in
ag
e a
nd
 
AB
No
ne
No
ne
29
3
pT
4N
2M
xa
11
0
III
0
4
De
hi
sc
en
ce
, S
er
om
a
M
an
ua
l d
ra
in
ag
e
No
ne
No
ne
36
4
pT
3N
0M
x
9
I
I
0
0
Se
ro
m
a
Pe
rin
ea
l i
rri
ga
tio
n
Ile
us
TP
N
41
5
pT
3N
0M
x
10
0
0
0
1
No
ne
No
ne
Ile
us
, u
rin
ar
y r
ete
n-
tio
n, 
ab
sc
es
s r
ig
ht
 
bu
tto
ck
I&
D 
ab
sc
es
s
32
6
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
7
pT
3N
0M
1
13
IV
II
M
iss
in
g
M
iss
in
g
De
hi
sc
en
ce
, I
nf
ec
tio
n
No
ne
UT
I
AB
 fo
r U
TI
34
8
pT
2N
2M
1
6
0
0
2
M
iss
in
g
No
ne
No
ne
Ur
in
ar
y r
ete
nt
io
n
Ta
m
su
lo
sin
e
20
9
pT
0N
0M
x
6
II
III
3
M
iss
in
g
Se
ro
m
a
M
an
ua
l d
ra
in
ag
e
No
ne
No
ne
19
10
pT
3N
1M
x
20
III
0
M
iss
in
g
M
iss
in
g
Se
ro
m
a
No
ne
Ile
us
, p
ne
um
on
ia,
 
de
lir
iu
m
TP
N,
 A
B 
fo
r p
ne
u-
m
on
ia,
 ha
ld
ol
33
11
pT
0N
0M
x
8
0
0
M
iss
in
g
3
No
ne
No
ne
Ur
in
ar
y r
ete
nt
io
n
No
ne
31
Techniques in Coloproctology 
1 3
drainage and antibiotic therapy for 7 days. The last patient 
with a complicated wound healing at 30 days developed per-
ineal pain secondary to a non-infected perineal seroma that 
required manual drainage in the outpatient clinic. There were 
no cases of flap necrosis. With a total of four complicated 
perineal wounds at 30 days and no flap failures, predefined 
feasibility criteria were met.
Two more patients had perineal seroma, but both resolved 
within 30 days and without further treatment. In the remain-
ing four patients, healing of the perineal wound was unevent-
ful. Perineal pain at 7 days was reported for seven patients 
with a median VAS score of 0. Perineal pain at 30 days was 
reported for six patients with a median VAS score of 1. Dur-
ing follow-up, there were no readmissions, and no radio-
logical or surgical reinterventions. Additional postoperative 
complications included ileus (n = 3), unrelated abscess on 
buttock (n = 1), urinary retention (n = 4), urinary tract infec-
tion (n = 2), pneumonia (n = 1), and delirium (n = 1).
Discussion
This pilot study aimed to determine the feasibility of the 
GT-flap in routine perineal reconstruction after APR. The 
GT-flap was technically feasible with midline closure in all 
patients, except for one patient in whom more perineal skin 
had to be excised for oncological reasons. The flap added 
only limited additional theatre time. The majority of patients 
had uncomplicated perineal wound healing at 30 days post-
operatively without any flap failure, thereby fulfilling our 
predefined feasibility criteria. Retrospective analysis of two 
cases of wound dehiscence revealed the critical part of the 
procedure, namely planning the appropriate width of the 
skin island that still allows for tension-free closure in the 
midline.
The GT-flap is only a valuable option if the perineal skin 
and subcutaneous fat can be maximally preserved from an 
oncological point of view. Therefore, distal rectal cancer 
without involvement of the perineal skin and subcutane-
ous fat requiring APR with a certain extent of resection of 
the levator muscles seems to be the optimal indication. If 
additional perineal skin has to be excised, for example, in 
case of advanced anal cancer or radiation-induced skin fibro-
sis, there is a need for flap-assisted closure that adds a skin 
island, such as the VRAM flap.
The GT-flap has a favourable profile, compared to exist-
ing literature on flap repair [7, 9]. There seems to be no par-
tial necrosis of the flap or total flap loss, as can be observed 
with muscle flaps, although the sample size is still small 
[18]. The procedure can be combined with laparoscopy, 
contrary to conventional VRAM flaps for example. In addi-
tion, median additive theatre time was only 38 min, which 
included a learning curve and time needed for photograph-
ing the procedure. This is likely to decline in the future 
with increasing experience. Another benefit is the ease of 
flap harvesting, not necessarily requiring a plastic surgeon. 
Nonetheless, the procedure should preferably be performed 
by a surgeon already familiar with harvesting perforator 
flaps, or after initially being proctored by a plastic surgeon. 
Injury to the perforators can have serious consequences. If 
the flap is raised too large, this will lead to undue tension 
of the perineal skin, which can result in a major dehiscence. 
However, these basic principles of the technique are quite 
simple and easy to learn.
Another advantage of the GT-flap over other options is the 
symmetrical midline scarring, thereby preserving the gluteal 
cleft and restoring normal perineal aesthetics (Fig. 3). This 
is a major advantage compared to the VRAM or conven-
tional gluteal flaps (e.g., V–Y transposition, SGAP, IGAP), 
which leave both large and visible scarring. Furthermore, no 
dissection of muscle is performed. Patients are allowed to 
mobilise directly. The GT-flap seems to avoid problems with 
balance, sitting or walking secondary to muscle weakness 
or pain that is often seen after gluteal muscle transpositions. 
Considering these benefits, the GT-flap may be very attrac-
tive for routine perineal wound closure after APR.
In the current pilot study with its small sample size, we 
found no distinct improvement in perineal wound healing 
rate compared to recent literature on various closure tech-
niques after APR [2, 7, 19]. In addition, when compared 
to outcomes from our institution (and two other hospi-
tals) after APR with primary layered closure and pedicled 
omentoplasty, we observe similar wound healing rates 
[20]. However, this should be interpreted with caution, 
as this study was not powered to evaluate the efficacy of 
Fig. 2  Perineal wound dehiscence 2.5 cm in depth with mild inflam-
mation following abdominoperineal resection with insertion of glu-
teal turnover flap. The underlying subcutis of the flap is still viable 
(white arrow), and ensures that there is no atmospheric connection to 
the intra-abdominal cavity
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the GT-flap. Due to the study design, it was also not pos-
sible to assess the impact of the GT-flap on the risk of 
long-term perineal complications such as perineal hernia. 
It is our feeling that the flap may add strength to the neo-
pelvic floor by anchoring the strong dermis to the con-
tra-lateral remnants of the levator muscles. Future study 
should evaluate whether this provides sufficient support 
to potentially prevent perineal hernia in the long term. A 
recent publication by Chasapi et al. reported on a similar 
reconstructive procedure in 14 patients having APR for 
anorectal cancer [21]. The type of flap used differed from 
the technique described here in that the flap was detached 
from the gluteal fascia with one remaining perforator for 
blood supply. They showed favourable outcome with only 
1 patient suffering from superficial skin dehiscence, and 1 
developing a perineal hernia 7 months after surgery. These 
findings support our feeling that in selected patients, adja-
cent gluteal skin and subcutaneous fat can be relatively 
easily used for perineal closure after APR, with the poten-
tial advantages of reduced perineal morbidity by filling 
the space of the resected anal sphincter complex. The next 
step is conducting a randomised controlled trial to deter-
mine the effectiveness of this intervention in reducing per-
ineal morbidity after APR, both short term and long term, 
comparing GT-flap with other flaps or other techniques 
for perineal closure reporting promising outcomes, such 
as biomesh [22].
Conclusions
The GT-flap is a technically feasible and safe method for 
perineal wound closure after APR in patients with primary 
or recurrent rectal cancer if no additional perineal skin 
has to be sacrificed. The procedure is relatively quick and 
easily applicable, and seems associated with no appar-
ent donor site morbidity or scarring. Further research is 
warranted to assess the potential for reducing perineal 
wound morbidity and to evaluate long-term quality of life.
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